URGN FY 2020 Earnings — UroGen Pharma Ltd. Revenue & Financial Results | Market Cap Arena

URGNUroGen Pharma Ltd.

$927M

FY 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$12M+65450.0% YoY

Gross Profit

$11M91.4% margin

Operating Income

-$127M-1074.2% margin

Net Income

-$128M-1088.9% margin

EPS (Diluted)

$-5.90

Cash Flow

Operating Cash Flow

-$106M

Free Cash Flow

-$107M

Stock-Based Comp.

$28M

Balance Sheet

Total Assets

$122M

Total Liabilities

$26M

Stockholders' Equity

$96M

Cash & Equivalents

$53M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$12M	$18,000	+65450.0%
Gross Profit	$11M	$18,000	+59844.4%
Operating Income	-$127M	-$109M	-15.8%
Net Income	-$128M	-$105M	-22.2%